Drug Interactions with Irbesartan
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 40 (8) , 605-614
- https://doi.org/10.2165/00003088-200140080-00004
Abstract
Irbesartan is an angiotensin II receptor antagonist indicated for the treatment of patients with hypertension. Although irbesartan does not require biotransformation for its pharmacological activity,...Keywords
This publication has 34 references indexed in Scilit:
- Effects of the Antifungal Agents on Oxidative Drug MetabolismClinical Pharmacokinetics, 2000
- Dose-Related Efficacy of Irbesartan for HypertensionHypertension, 1998
- Lack of Effect of Food on the Oral Bioavailability of Irbesartan in Healthy Male VolunteersThe Journal of Clinical Pharmacology, 1998
- Effect of Hydrochlorothiazide on the Pharmacokinetics and Pharmacodynamics of the Angiotensin II Blocker IrbesartanClinical Drug Investigation, 1997
- Combination therapy for systemic hypertensionThe American Journal of Cardiology, 1995
- Drug Interactions with AntacidsDrug Safety, 1994
- Pharmacokinetic Drug Interactions with ACE InhibitorsClinical Pharmacokinetics, 1993
- Captopril and nifedipine in combination for moderate to severe essential hypertension.Hypertension, 1987
- Influence of Food on the Bioavailability of DrugsClinical Pharmacokinetics, 1978
- Influence of food and diet on gastrointestinal drug absorption: A reviewJournal of Pharmacokinetics and Biopharmaceutics, 1977